Jerson Flores-Castillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jerson Flores-Castillo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- John Vargas-Urbina
Department of Neurosurgery, Skull Base and Functional Neurosurgery Units, National Institute of Neurological Sciences, Lima, Peru
3 shared publications - Gabriel Ponce-Manrique
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Lima, Peru
2 shared publications - Giuseppe Rojas-Panta
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Lima, Peru
2 shared publications - Raúl Martinez-Silva
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Lima, Peru
2 shared publications - Alfonso Martin Cabello-Vilchez
Alexander von Humboldt Institute of Tropical Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru
1 shared publication - Dalila Martínez Medina
Department of Infectious, Tropical and Dermatological Diseases, Hospital Nacional Cayetano Heredia, Lima, Peru
1 shared publication
Latest Publications
- Open Access
- 2 May 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 166
Encephalitis-causing free-living amoebic infections in children: A rare and fatal disease
Background: Brain infection by free-living amoebae can present as granulomatous amoebic encephalitis if caused by Acanthamoeba spp. or Balamuthia mandrillaris, or as primary amoebic meningoencephalitis if caused by Naegleria fowleri, the latter with high morbidity and mortality. Diagnosis is made by studying cerebrospinal fluid or tissue samples by direct microscopy, culture, polymerase chain reaction, or immunofluorescence. There is no specific treatment, and there are only reports of success with prolonged use of combined drugs. Cases Description: We present five cases with a diagnosis of brain infection by free-living amoebae treated at the Hospital Almenara. The patients received surgical treatment, and four of them also received antiparasitic treatment; in one case, the diagnosis was post-mortem. Antiparasitic treatment consisted of a combination of miltefosine, voriconazole, and albendazole mainly, with an average time of 4.8 months. All cases were diagnosed after the initial surgery, and two patients died. Diagnosis in all cases was by direct microscopy, but typing of the free-living amoeba involved was not possible. Conclusion: Brain infection by free-living amoebae is a disease with high morbimortality, which requires early diagnosis for a better prognosis if long-term combined treatment is established.
- 2 May 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 166
Open AccessEncephalitis-causing free-living amoebic infections in children: A rare and fatal disease
Background: Brain infection by free-living amoebae can present as granulomatous amoebic encephalitis if caused by Acanthamoeba spp. or Balamuthia mandrillaris, or as primary amoebic meningoencephalitis if caused by Naegleria fowleri, the latter with high morbidity and mortality. Diagnosis is made by studying cerebrospinal fluid or tissue samples by direct microscopy, culture, polymerase chain reaction, or immunofluorescence. There is no specific treatment, and there are only reports of success with prolonged use of combined drugs. Cases Description: We present five cases with a diagnosis of brain infection by free-living amoebae treated at the Hospital Almenara. The patients received surgical treatment, and four of them also received antiparasitic treatment; in one case, the diagnosis was post-mortem. Antiparasitic treatment consisted of a combination of miltefosine, voriconazole, and albendazole mainly, with an average time of 4.8 months. All cases were diagnosed after the initial surgery, and two patients died. Diagnosis in all cases was by direct microscopy, but typing of the free-living amoeba involved was not possible. Conclusion: Brain infection by free-living amoebae is a disease with high morbimortality, which requires early diagnosis for a better prognosis if long-term combined treatment is established.
- Open Access
- 3 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 5
Unusual brain metastasis from colon cancer
Background: Brain metastases due to colorectal cancer correspond to 3–5% of all brain metastases. The prognostic factors are based on age, functional status, and single metastasis. Its management is multidisciplinary, with poor prognosis despite the management. Case Description: A case of a 64-year-old male presented with symptoms of headache, disorientation, and nausea. The enhanced magnetic resonance image showed a mass in the right frontal horn of the lateral ventricle, contrast enhancing, with irregular borders, but defined, without restriction in diffusion-weighted images, associated with obstructive hydrocephalus. The investigations in search of a primary neoplasm were negative. A ventricular endoscopic approach was performed, with total resection of the lesion. Four months later, he developed a bowel obstruction with surgical management to control the primary, followed by chemotherapy and radiotherapy, with a current survival longer than 1 year. Conclusion: Brain metastases due to colorectal cancer are rare, and usually, when diagnosed, there are already pulmonary and hepatic metastases. Multidisciplinary management is recommended, where surgical management can be included in selected cases with controlled systemic disease, good functional condition, and single metastasis.
- 3 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 5
Open AccessUnusual brain metastasis from colon cancer
Background: Brain metastases due to colorectal cancer correspond to 3–5% of all brain metastases. The prognostic factors are based on age, functional status, and single metastasis. Its management is multidisciplinary, with poor prognosis despite the management. Case Description: A case of a 64-year-old male presented with symptoms of headache, disorientation, and nausea. The enhanced magnetic resonance image showed a mass in the right frontal horn of the lateral ventricle, contrast enhancing, with irregular borders, but defined, without restriction in diffusion-weighted images, associated with obstructive hydrocephalus. The investigations in search of a primary neoplasm were negative. A ventricular endoscopic approach was performed, with total resection of the lesion. Four months later, he developed a bowel obstruction with surgical management to control the primary, followed by chemotherapy and radiotherapy, with a current survival longer than 1 year. Conclusion: Brain metastases due to colorectal cancer are rare, and usually, when diagnosed, there are already pulmonary and hepatic metastases. Multidisciplinary management is recommended, where surgical management can be included in selected cases with controlled systemic disease, good functional condition, and single metastasis.
- Open Access
- 22 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 440
Pandemic impact on aneurysmal subarachnoid hemorrhage in Peru’s high COVID-19 lethality setting: A public institutional experience
The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic.
- 22 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 440
Open AccessPandemic impact on aneurysmal subarachnoid hemorrhage in Peru’s high COVID-19 lethality setting: A public institutional experience
The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic.